Paclitaxel, Carboplatin, and Bevacizumab in Advanced Cervical Cancer: A Treatment Response and Safety Analysis

BACKGROUND: Trials reported there are beneficial effects of the addition of bevacizumab to chemotherapy in advanced cervical cancer but might have adverse effects. The purposes of the study were to evaluate the treatment response and safety of the addition of bevacizumab to paclitaxel plus carboplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Wanjun, Yang, Jia, Jiang, Yongxian, Chen, Wenwen, Wang, Yixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391439/
https://www.ncbi.nlm.nih.gov/pubmed/32774193
http://dx.doi.org/10.1177/1559325820941351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391439/
https://www.ncbi.nlm.nih.gov/pubmed/32774193
http://dx.doi.org/10.1177/1559325820941351

Ejemplares similares